Analysis of Factors Affecting Compliance Treatment of Pulmonary Tuberculosis Patients in the Work Area

Article Sidebar

PDF
Published: Aug 4, 2025
DOI: https://doi.org/10.55885/jchp.v5i2.712
Keywords:
Attitude, Knowledge, Belief, Duration of Treatment, Supervisor Swallow Drugs (PMO), Support Family

Main Article Content

Senang Hati Bazikho
Master of Public Health Study Program, Institut Kesehatan Helvetia, Indonesia
Asriwati Amirah
Master of Public Health Study Program, Institut Kesehatan Helvetia, Indonesia
Miskah Afriani Nasution
Psychology study program, Institut Kesehatan Helvetia, Indonesia
Setia Megawati Hutajulu
Master of Public Health Study Program, Institut Kesehatan Helvetia, Indonesia
Muflih
D3 Nursing Study Program, Institut Kesehatan Helvetia, Indonesia

Abstract

Pulmonary tuberculosis (TB) is a disease infectious direct and is threat big for development source Power man so that need get more attention​ Serious from all parties. As for objective in study This is for analyze factor affecting​ compliance treatment Pulmonary Tuberculosis Patients in the Work Area Service Health Regency South Nias 2024. Regency South Nias has amount cases of pulmonary TB that every the year experience improvement, so that own potential height non-compliance patient in run Pulmonary TB treatment. Type study This use design study quantitative with cross sectional study approach. Sample in study This totaling 72 respondents Pulmonary TB sufferers in the Work Area Service Health Regency South Nias 2024. Based on results analysis that knowledge (p=0.003), duration of treatment (p=0.000), supervisor swallow drug (PMO) (p=0.000) there is influence support family (p=0.000) has influence to compliance Pulmonary Tuberculosis Treatment in Work Areas Service Health Regency South Nias 2024. As for the suggestions in study This expected to officer health For give counseling to TB patients under surveillance family (PMO) towards compliance treatment patient Pulmonary tuberculosis is complete appropriate on time.

Article Details

How to Cite
Bazikho, S. H., Amirah, A. ., Nasution, M. A. . ., Hutajulu, S. M. ., & Muflih, M. (2025). Analysis of Factors Affecting Compliance Treatment of Pulmonary Tuberculosis Patients in the Work Area. Journal of Community Health Provision, 5(2), 70-80. https://doi.org/10.55885/jchp.v5i2.712
Issue
Vol. 5 No. 2 (2025): Journal of Community Health Provision
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

References

Atif, M., Munir, K., Malik, I., Al-Worafi, Y. M., Mushtaq, I., & Ahmad, N. (2022). Perceptions of healthcare professionals and patients on the role of the pharmacist in TB management in Pakistan: A qualitative study. Frontiers in Pharmacology, 13, 965806. https://doi.org/10.3389/fphar.2022.965806

Caminero, J. A., Sotgiu, G., Zumla, A., & Migliori, G. B. (2010). Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. The Lancet infectious diseases, 10(9), 621-629.

Campbell, I. A., & Bah-Sow, O. (2006). Pulmonary tuberculosis: diagnosis and treatment. Bmj, 332(7551), 1194-1197. https://doi.org/10.1136/bmj.332.7551.1194

Collins, D., Hafidz, F., & Mustikawati, D. (2017). The economic burden of tuberculosis in Indonesia. The International Journal of Tuberculosis and Lung Disease, 21(9), 1041-1048. https://doi.org/10.5588/ijtld.16.0898

Conradie, F., Diacon, A. H., Ngubane, N., Howell, P., Everitt, D., Crook, A. M., ... & Spigelman, M. (2020). Treatment of highly drug-resistant pulmonary tuberculosis. New England Journal of Medicine, 382(10), 893-902. https://doi.org/10.1056/NEJMoa1901814

Falzon, D., Schünemann, H. J., Harausz, E., González-Angulo, L., Lienhardt, C., Jaramillo, E., & Weyer, K. (2017). World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. European Respiratory Journal, 49(3). https://doi.org/10.1183/13993003.02308-2016

Hevey, D. (2007). Adherence to health recommendations. In Cardiovascular prevention and rehabilitation (pp. 293-300). London: Springer London. https://doi.org/10.1007/978-1-84628-502-8_35

Hossain, M. R., Islam, M. S., Akter, S., Anisuzzaman, A. H. M., Abdullah-Al-Maruf, M., & Mohammed, N. (2023). Impact of education on non-compliance and MDR TB risk: specialized hospital study. Saudi J Med, 8(12), 659-663. https://doi.org/10.36348/sjm.2023.v08i12.007

Jonas, K., Crutzen, R., van den Borne, B., & Reddy, P. (2017). Healthcare workers’ behaviors and personal determinants associated with providing adequate sexual and reproductive healthcare services in sub-Saharan Africa: a systematic review. BMC pregnancy and childbirth, 17(1), 86. https://doi.org/10.1186/s12884-017-1268-x

Kurnianingsih, W., Tamtomo, D. G., & Murti, B. (2020). The effect of non-compliance with medication on multidrug resistant of tuberculosis. Journal of Epidemiology and Public Health, 5(4), 442-450.

Mobaderi, T., Kazemnejad, A., & Salehi, M. (2025). Clustering and modeling joint-trajectories of HIV/AIDS and tuberculosis mortality rates using bayesian multi-process latent growth model: A global study from 1990 to 2021. BMC Infectious Diseases, 25(1), 330. https://doi.org/10.1186/s12879-025-10715-x

Mukuka, B. (2024). A Study to Assess Anti-TB Treatment Compliance, Factors Predictive for Poor Adherence and Perpetual Defaulting among Patient Living with TB in Namuseche Chipata Eastern Province–Zambia. Mukuka Brian. https://doi.org/10.38124/ijisrt/IJISRT24OCT005

Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., ... & Seaworth, B. (2019). Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline. American journal of respiratory and critical care medicine, 200(10), e93-e142. https://doi.org/10.1164/rccm.201909-1874ST

Nezenega, Z. S., Perimal-Lewis, L., & Maeder, A. J. (2020). Factors influencing patient adherence to tuberculosis treatment in Ethiopia: a literature review. International journal of environmental research and public health, 17(15), 5626. https://doi.org/10.3390/ijerph17155626

Sari, Y. S., & Kamil, H. (2022). The patient with multi-drug resistant–pulmonary tuberculosis adherence to treatment: a qualitative study. Enfermería clínica, 32, S58-S61. https://doi.org/10.1016/j.enfcli.2022.03.019

Surendra, H., Elyazar, I. R., Puspaningrum, E., Darmawan, D., Pakasi, T. T., Lukitosari, E., ... & Hamers, R. L. (2023). Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide analysis of programme data and health system vulnerabilities. medRxiv, 2023-02. https://doi.org/10.1101/2023.02.09.23285740

Swarna Nantha, Y., Puri, A., Mohamad Ali, S. Z., Suppiah, P., Che Ali, S. A., Ramasamy, B., & Ibrahim, I. M. (2017). Epidemiology of latent tuberculosis infection among patients with and without diabetes mellitus. Family practice, 34(5), 532-538. https://doi.org/10.1093/fampra/cmx017

Uplekar, M. W., & Shepard, D. S. (1991). Treatment of tuberculosis by private general practitioners in India. Tubercle, 72(4), 284-290. https://doi.org/10.1016/0041-3879(91)90055-W

van Dulmen, S., Sluijs, E., Van Dijk, L., de Ridder, D., Heerdink, R., & Bensing, J. (2007). Patient adherence to medical treatment: a review of reviews. BMC health services research, 7(1), 55. https://doi.org/10.1186/1472-6963-7-55

World Health Organization, & World Health Organization Staff. (2013). Global tuberculosis report 2013. Switzerland: World health organization.

Zumla, A., Chakaya, J., Centis, R., D'Ambrosio, L., Mwaba, P., Bates, M., ... & Migliori, G. B. (2015). Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies. The Lancet Respiratory Medicine, 3(3), 220-234.